ciprofloxacin has been researched along with Colitis in 20 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin is considered to be a safe and effective treatment for acute infectious colitis." | 7.80 | Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis. ( Cheung, DY; Cho, HJ; Cho, SH; Kim, JI; Kim, JK; Kim, SS; Lee, HJ; Sung, HY, 2014) |
| " In the present study, therapeutic role of the antibacterial drugs rifampicin and ciprofloxacine were investigated in comparison to spironolactone, an enzyme inducer, in 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis of the rats." | 7.79 | A study comparing the efficacy of antimicrobial agents versus enzyme (P-gp) inducers in the treatment of 2,4,6 trinitrobenzenesulfonic acid-induced colitis in rats. ( Celikel, C; Cetinel, S; Dulger, GA; Imeryuz, N; Kabasakal, L; Kan, B; Orun, O; Toklu, HZ; Yuksel, M, 2013) |
| "Mice treated with ciprofloxacin (7." | 5.34 | Immunomodulatory effects of ciprofloxacin in TNBS-induced colitis in mice. ( Barazovsky, E; Fabian, I; Halperin, D; Klausner, J; Lahat, G; Rabau, M; Shalit, I, 2007) |
| "At the Clinic for infectious and dermatovenerologic diseases in Novi Sad a prospective randomized, simple, blind investigation of differently organized treatments of salmonellal gastroenterocolitis (symptomatic therapies, ampicillin, co-trimoxazole and ciprofloxacine) was carried out." | 5.07 | [Therapy of salmonella gastroenterocolitis]. ( Brkić, S; Celanović, M; Jovanović, J; Knezević, K; Madle-Samardzija, N, 1994) |
| "Ciprofloxacin is considered to be a safe and effective treatment for acute infectious colitis." | 3.80 | Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis. ( Cheung, DY; Cho, HJ; Cho, SH; Kim, JI; Kim, JK; Kim, SS; Lee, HJ; Sung, HY, 2014) |
| " In the present study, therapeutic role of the antibacterial drugs rifampicin and ciprofloxacine were investigated in comparison to spironolactone, an enzyme inducer, in 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis of the rats." | 3.79 | A study comparing the efficacy of antimicrobial agents versus enzyme (P-gp) inducers in the treatment of 2,4,6 trinitrobenzenesulfonic acid-induced colitis in rats. ( Celikel, C; Cetinel, S; Dulger, GA; Imeryuz, N; Kabasakal, L; Kan, B; Orun, O; Toklu, HZ; Yuksel, M, 2013) |
| "While acute pancreatitis is among the differential diagnosis for elevated lipase levels, several other causes of elevated lipase levels have been identified including several reports Salmonella species as a causative agent." | 1.46 | Salmonella colitis as an unusual cause of elevated serum lipase. ( Buchan, D; Dean, R; Gill, D, 2017) |
| "Ciprofloxacin is a GP-BAR1 ligand." | 1.37 | The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. ( Baldelli, F; Bifulco, G; Chini, MG; Cipriani, S; Distrutti, E; Donini, A; Fiorucci, S; Mencarelli, A; Renga, B, 2011) |
| " Transient adverse effects of mild to moderate severity included agitation, excitement and muscle fasciculation, followed by lethargy, cutaneous edema and loss of appetite developed in all seven horses after i." | 1.36 | Pharmacokinetics and toxicity of ciprofloxacin in adult horses. ( Edman, J; Papich, MG; Pusterla, N; Wiebe, VJ; Wilson, WD; Yamarik, TA, 2010) |
| "Colitis was ameliorated by oral administration of broad-spectrum antibiotics." | 1.35 | Colonic gene expression profile in NHE3-deficient mice: evidence for spontaneous distal colitis. ( Bai, A; Ghishan, FK; Kiela, PR; Larmonier, CB; Laubitz, D; Lipko, MA; Midura-Kiela, MT; Thurston, RD, 2008) |
| "Mice treated with ciprofloxacin (7." | 1.34 | Immunomodulatory effects of ciprofloxacin in TNBS-induced colitis in mice. ( Barazovsky, E; Fabian, I; Halperin, D; Klausner, J; Lahat, G; Rabau, M; Shalit, I, 2007) |
| "The development of toxic megacolon as a complication of infectious colitis is rare." | 1.33 | Toxic megacolon complicating Escherichia coli O157 infection. ( Koerner, RJ; McElroy, J; Nayar, DM; Pai, P; Vetrivel, S, 2006) |
| "Antibiotics both prevent and treat the colitis through correction of this primary bacterial alteration." | 1.31 | Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. ( Doyle, JS; Fedorak, RN; Jewell, LD; Madsen, KL; Rennie, RP; Tavernini, MM, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrison, CA | 1 |
| Laubitz, D | 2 |
| Midura-Kiela, MT | 2 |
| Jamwal, DR | 1 |
| Besselsen, DG | 1 |
| Ghishan, FK | 2 |
| Kiela, PR | 2 |
| Gupta, NK | 1 |
| Masia, R | 1 |
| Toklu, HZ | 1 |
| Kabasakal, L | 1 |
| Imeryuz, N | 1 |
| Kan, B | 1 |
| Celikel, C | 1 |
| Cetinel, S | 1 |
| Orun, O | 1 |
| Yuksel, M | 1 |
| Dulger, GA | 1 |
| Sung, HY | 1 |
| Kim, JI | 1 |
| Lee, HJ | 1 |
| Cho, HJ | 1 |
| Cheung, DY | 1 |
| Kim, SS | 1 |
| Cho, SH | 1 |
| Kim, JK | 1 |
| Cash, BD | 1 |
| Dean, R | 1 |
| Gill, D | 1 |
| Buchan, D | 1 |
| Shah, MB | 1 |
| Sundararajan, S | 1 |
| Crawford, CV | 1 |
| Hartono, C | 1 |
| Yamarik, TA | 1 |
| Wilson, WD | 1 |
| Wiebe, VJ | 1 |
| Pusterla, N | 1 |
| Edman, J | 1 |
| Papich, MG | 1 |
| Cipriani, S | 1 |
| Mencarelli, A | 1 |
| Chini, MG | 1 |
| Distrutti, E | 1 |
| Renga, B | 1 |
| Bifulco, G | 1 |
| Baldelli, F | 1 |
| Donini, A | 1 |
| Fiorucci, S | 1 |
| Chen, J | 1 |
| Cachay, ER | 1 |
| Hunt, GC | 1 |
| Nayar, DM | 1 |
| Vetrivel, S | 1 |
| McElroy, J | 1 |
| Pai, P | 1 |
| Koerner, RJ | 1 |
| Lahat, G | 1 |
| Halperin, D | 1 |
| Barazovsky, E | 1 |
| Shalit, I | 1 |
| Rabau, M | 1 |
| Klausner, J | 1 |
| Fabian, I | 1 |
| Navarro-Llavat, M | 1 |
| Domènech, E | 1 |
| Masnou, H | 1 |
| Ojanguren, I | 1 |
| Mañosa, M | 1 |
| Lorenzo-Zúñiga, V | 1 |
| Boix, J | 1 |
| Gassull, MA | 1 |
| Myers, AL | 1 |
| Colombo, J | 1 |
| Jackson, MA | 1 |
| Harrison, CJ | 1 |
| Roberts, CR | 1 |
| Larmonier, CB | 1 |
| Bai, A | 1 |
| Lipko, MA | 1 |
| Thurston, RD | 1 |
| Brkić, S | 1 |
| Knezević, K | 1 |
| Celanović, M | 1 |
| Jovanović, J | 1 |
| Madle-Samardzija, N | 1 |
| Rivera, P | 1 |
| Pamos, S | 1 |
| Cuquerella, J | 1 |
| Ferrer, L | 1 |
| Tomé, A | 1 |
| Ortí, E | 1 |
| Salvador, I | 1 |
| Medina, E | 1 |
| Madsen, KL | 1 |
| Doyle, JS | 1 |
| Tavernini, MM | 1 |
| Jewell, LD | 1 |
| Rennie, RP | 1 |
| Fedorak, RN | 1 |
| Rath, HC | 1 |
| Schultz, M | 1 |
| Freitag, R | 1 |
| Dieleman, LA | 1 |
| Li, F | 1 |
| Linde, HJ | 1 |
| Schölmerich, J | 1 |
| Sartor, RB | 1 |
| Liao, WC | 1 |
| Cappell, MS | 1 |
1 review available for ciprofloxacin and Colitis
| Article | Year |
|---|---|
Collagenous duodeno-ileo-colitis with transient IgG deficiency preceded by Yersinia enterocolitica intestinal infection: case report and review of literature.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Budesonide; Chronic Disease; Ciprofloxacin; Colitis | 2007 |
1 trial available for ciprofloxacin and Colitis
| Article | Year |
|---|---|
[Therapy of salmonella gastroenterocolitis].
Topics: Adolescent; Adult; Ampicillin; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Coliti | 1994 |
18 other studies available for ciprofloxacin and Colitis
| Article | Year |
|---|---|
Sexual Dimorphism in the Response to Broad-spectrum Antibiotics During T Cell-mediated Colitis.
Topics: Adoptive Transfer; Animals; Anti-Bacterial Agents; CD4-Positive T-Lymphocytes; Cecum; Ciprofloxacin; | 2019 |
Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Colitis; Cord Blood Stem Cell Transplantation; Crohn Di | 2013 |
A study comparing the efficacy of antimicrobial agents versus enzyme (P-gp) inducers in the treatment of 2,4,6 trinitrobenzenesulfonic acid-induced colitis in rats.
Topics: Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ciprofloxac | 2013 |
Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infectio | 2014 |
Board Review Vignette: Segmental Colitis Associated With Diverticulosis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colitis; Colon, Sigmoid; Colonoscopy; Diverticulosis, Colonic; | 2016 |
Salmonella colitis as an unusual cause of elevated serum lipase.
Topics: Abdominal Pain; Anti-Bacterial Agents; Ciprofloxacin; Colitis; Diagnosis, Differential; Diarrhea; Hu | 2017 |
Malakoplakia-induced diarrhea in a kidney transplant recipient.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colitis; Colonoscopy; Diarrhea; Endoscopy; Humans; Intestinal | 2010 |
Pharmacokinetics and toxicity of ciprofloxacin in adult horses.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colitis; Endotoxemia; Female; Half-Life; Horse Diseas | 2010 |
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis.
Topics: Animals; Cholera Toxin; Ciprofloxacin; Colitis; Haptoglobins; Immunity; Intestinal Mucosa; Ligands; | 2011 |
Klebsiella oxytoca: a rare cause of severe infectious colitis: first North American case report.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Colitis; Colon, Sigmoid; Humans; Klebsiella Infections; | 2004 |
Toxic megacolon complicating Escherichia coli O157 infection.
Topics: Adult; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin; Colitis; Colon; Escherichia coli | 2006 |
Immunomodulatory effects of ciprofloxacin in TNBS-induced colitis in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ceftazidime; Ciprofloxacin; Colitis; Colon | 2007 |
Tuberculous colitis mimicking Crohn disease.
Topics: Abdominal Pain; Adolescent; Anastomosis, Surgical; Anti-Infective Agents; Antitubercular Agents; App | 2007 |
Colonic gene expression profile in NHE3-deficient mice: evidence for spontaneous distal colitis.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colitis; Colon; Gene Deletion; Gene Expression Profil | 2008 |
[Collagenous colitis: presentation of 12 cases].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammato | 1997 |
Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice.
Topics: Age Factors; Animals; Anti-Bacterial Agents; Bacteroides; Ciprofloxacin; Clostridium; Colitis; Enter | 2000 |
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.
Topics: Animals; Bacteroides; Ciprofloxacin; Colitis; Enterobacteriaceae; Female; HLA-B27 Antigen; Imipenem; | 2001 |
Treatment with ciprofloxacin of Aeromonas hydrophila associated colitis in a male with antibodies to the human immunodeficiency virus.
Topics: Adult; Aeromonas; Bacterial Infections; Ciprofloxacin; Colitis; HIV Seropositivity; Humans; Male; Op | 1989 |